Literature DB >> 30103332

Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort.

Meng-Shan Tan1, Ping Wang1, Fang-Chen Ma1, Jie-Qiong Li1, Chen-Chen Tan1, Jin-Tai Yu1, Lan Tan1.   

Abstract

Recent studies found the variants in Alzheimer's disease (AD) risk gene PLD3 were associated with cognitive function, but its detailed mechanism before typical AD onset was unknown. Our current study examined the impact of PLD3 common variant rs11667768 on cerebrospinal fluid (CSF) total-tau and phosphorylated-tau levels and structural MRI from the ADNI database. We found rs11667768 was significantly associated with CSF total-tau levels and hippocampal volumes at baseline and six-year follow-up in the total non-demented elderly group and the mild cognitive impairment subgroup, indicating a potential role of PLD3 common variants in influencing cognitive function through changing CSF total-tau levels and hippocampal volumes.

Entities:  

Keywords:  Alzheimer’s Disease neuroimaging initiative; PLD3; common variant; hippocampus; mild cognitive impairment;  tau

Mesh:

Substances:

Year:  2018        PMID: 30103332     DOI: 10.3233/JAD-180431

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  3 in total

1.  Quantification and characterization of the 5' exonuclease activity of the lysosomal nuclease PLD3 by a novel cell-based assay.

Authors:  Cedric Cappel; Adriana Carolina Gonzalez; Markus Damme
Journal:  J Biol Chem       Date:  2020-12-10       Impact factor: 5.157

2.  Cleavage of DNA and RNA by PLD3 and PLD4 limits autoinflammatory triggering by multiple sensors.

Authors:  Amanda L Gavin; Deli Huang; Tanya R Blane; Therese C Thinnes; Yusuke Murakami; Ryutaro Fukui; Kensuke Miyake; David Nemazee
Journal:  Nat Commun       Date:  2021-10-07       Impact factor: 17.694

3.  Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort.

Authors:  Yi Liu; Meng-Shan Tan; Zuo-Teng Wang; Wei Xu; Lan Tan
Journal:  BMC Neurol       Date:  2022-02-16       Impact factor: 2.903

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.